86 related articles for article (PubMed ID: 2967303)
1. Dyslipidemia and accelerated atherosclerosis.
Hazzard WR
Hosp Pract (Off Ed); 1988 May; 23(5A):41-50. PubMed ID: 2967303
[No Abstract] [Full Text] [Related]
2. Gestational hyperlipidemic pancreatitis caused by type III hyperlipoproteinemia with apolipoprotein E2/E2 homozygote.
Chuang TY; Chao CL; Lin BJ; Lu SC
Pancreas; 2009 Aug; 38(6):716-7. PubMed ID: 19629007
[No Abstract] [Full Text] [Related]
3. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
[No Abstract] [Full Text] [Related]
4. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
Feussner G; Dobmeyer J; Nissen H; Hansen TS
Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
[TBL] [Abstract][Full Text] [Related]
5. Genetics of type III hyperlipoproteinemia.
Feussner G; Piesch S; Dobmeyer J; Fischer C
Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
[TBL] [Abstract][Full Text] [Related]
6. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
[TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
Smelt AH
Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
[TBL] [Abstract][Full Text] [Related]
8. Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.
Feussner G; Wingen AM; Ziegler R
Metabolism; 1990 Nov; 39(11):1196-9. PubMed ID: 2233282
[TBL] [Abstract][Full Text] [Related]
9. Dysbetalipoproteinemia and clomipramine.
Holmes DT; Long P; Frohlich J
Am J Psychiatry; 2005 Jul; 162(7):1384-5. PubMed ID: 15994726
[No Abstract] [Full Text] [Related]
10. Simple precipitation-based method for the screening of type III hyperlipoproteinemia.
Nauck M; Glatt L; März W; Feussner G; Wieland H
Clin Chem; 1999 Jun; 45(6 Pt 1):909-11. PubMed ID: 10352005
[No Abstract] [Full Text] [Related]
11. Familial apolipoprotein E deficiency.
Schaefer EJ; Gregg RE; Ghiselli G; Forte TM; Ordovas JM; Zech LA; Brewer HB
J Clin Invest; 1986 Nov; 78(5):1206-19. PubMed ID: 3771793
[TBL] [Abstract][Full Text] [Related]
12. [Specific diagnosis of familial dysbetalipoproteinemia in Denmark. Report of a family study].
Gerdes LU; Faergeman O
Ugeskr Laeger; 1988 Jan; 150(4):230-2. PubMed ID: 3376331
[No Abstract] [Full Text] [Related]
13. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
Ziemer A; Göring HD
Hautarzt; 1993 Aug; 44(8):538-44. PubMed ID: 8376110
[TBL] [Abstract][Full Text] [Related]
14. Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.
Feussner G; Wagner A; Ziegler R
Hum Genet; 1993 Sep; 92(2):122-6. PubMed ID: 8370576
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
Wardell MR; Brennan SO; Janus ED; Fraser R; Carrell RW
J Clin Invest; 1987 Aug; 80(2):483-90. PubMed ID: 3038959
[TBL] [Abstract][Full Text] [Related]
16. Familial dysbetalipoproteinemia in three patients with apoE 2*(Arg136-->Cys) gene variant.
Vrablík M; Horínek A; Ceska R; Stulc T; Kvasnicka T
Physiol Res; 2003; 52(5):647-50. PubMed ID: 14535841
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
Utermann G
Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
[No Abstract] [Full Text] [Related]
18. Two Italian kindreds carrying the Arg136-->Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele.
Rolleri M; Vivona N; Emmanuele G; Cefalù AB; Pisciotta L; Guido V; Noto D; Fiore B; Barbagallo CM; Notarbartolo A; Travali S; Bertolini S; Averna MR
Nutr Metab Cardiovasc Dis; 2003 Apr; 13(2):93-9. PubMed ID: 12929622
[TBL] [Abstract][Full Text] [Related]
19. Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotype.
Feussner G; Ziegler R
J Intern Med; 1991 Aug; 230(2):183-6. PubMed ID: 1865171
[TBL] [Abstract][Full Text] [Related]
20. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
